MEDTECH COMMERCIALIZATION

From Medical Innovation
to Commercial Adoption.

Fractional commercial leadership for emerging medical technology companies navigating launch, clinical adoption, U.S. market entry and scalable growth.

20+Years in MedTech
30+Product Launches
OR → C-SUITEStrategy + Execution
THE COMMERCIALIZATION GAP

Great technology doesn't
commercialize itself.

FDA clearance, strong engineering and clinical evidence are critical milestones. But they don't automatically create adoption.

Ascend helps leadership teams determine who adopts first, why clinicians change, how the technology should be positioned, and what commercial model can scale.

CAPABILITIES

Strategy that moves
into execution.

Senior commercial expertise focused on the inflection points that determine whether innovative technologies become successful businesses.

01

Fractional Commercial Leadership

Executive-level commercial leadership without the overhead of a full-time hire. Strategy, priorities, team design and hands-on execution.

Learn more →
02

Go-to-Market Strategy

Market segmentation, positioning, pricing, channel strategy and a commercial model built for your stage.

Learn more →
03

Product Launch

Turn regulatory milestones into market momentum through disciplined pre-launch planning and launch execution.

Learn more →
04

Clinical Adoption & KOLs

Build clinical credibility through surgeon champions, advisory relationships, early adopters and reference centers.

Learn more →
05

Sales & Channel Development

Design direct, distributor and hybrid sales models that create repeatable growth rather than isolated wins.

Learn more →
06

U.S. Market Entry

A practical U.S. commercialization plan for international MedTech companies entering the world's largest device market.

Learn more →
BUILT FOR INFLECTION POINTS

When the stakes
change, the commercial
strategy should too.

Ascend is built for CEOs and leadership teams facing the moments where commercial decisions have outsized impact.

Preparing for FDA clearance
Recently cleared and preparing to launch
Entering the U.S. market
Recently funded and building commercial infrastructure
Early commercial and establishing repeatability
Scaling adoption, channels and revenue
THE ASCEND COMMERCIALIZATION FRAMEWORK

Build deliberately. Scale intelligently.

01

ASSESS

Market opportunity, commercial readiness and adoption barriers

02

POSITION

Value proposition, segmentation, clinical positioning and pricing

03

VALIDATE

KOL engagement, early adopters, market feedback and pilots

04

LAUNCH

Sales strategy, education, reference sites and execution

05

SCALE

Commercial organization, channel expansion and revenue optimization

WHY ASCEND

Experience where strategy
meets the operating room.

Ascend combines executive-level commercial strategy with hands-on experience across complex procedural medical technology.

OrthopedicsSpineNeurosurgerySurgical NavigationRoboticsAdvanced ImagingAI-Enabled TechnologyCapital EquipmentASC Strategy
DM
FOUNDER & MANAGING DIRECTOR

Daniel Moore

Medical technology commercialization executive with more than two decades of experience spanning medical devices, surgical technologies and emerging MedTech.

Daniel works directly with founders, CEOs and commercial teams to develop go-to-market strategies, accelerate clinical adoption and build scalable commercial organizations.

START A CONVERSATION

Your technology has reached
an inflection point.

Make sure your commercial strategy is ready for what comes next.

Confidential conversations with founders, CEOs and MedTech leadership teams.